Atlas Trials

Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients

Clinical trial NCT04345523 · COMPLETED

Trial details

NCT number
NCT04345523
Sponsor
Cristina Avendaño Solá
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-04-03
Primary completion
2021-02-05
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.